Ojemda
(oh-JEM-dah)
A drug used to treat children aged 6 months and older with low-grade glioma (a type of brain tumor) that has certain mutations (changes) in the BRAF gene. It is used in patients whose tumor came back or did not get better after treatment with other therapy. It is also being studied in the treatment of other types of cancer. Ojemda blocks certain proteins made by the mutated BRAF gene, which may help keep tumor cells from growing. It is a type of kinase inhibitor. Also called tovorafenib.